Strainsforpains, Inc. Shareholder Update . New York, NY, May 2 2023—STRAINSFORPAINS,INC. ( OTC Markets: EBYH). The company is excited to announce that it has entered into the next phase of our growth plan, which is expected to bring about a substantial increase in revenues. The launch of the iOS version of our Strainsforpains telehealth app, along with new business models that take advantage of advertising instead of a subscription model, is expected to drive this growth.The Beta testing for our iOS version is coming to a close and we are optimistic for the potential for revenues to reach millions of dollars. Our revenue streams will come from various joint ventures, distribution of alternative health and CBD products that will utilize our Pennsylvania facility, and our app revenues. Mr. Shainberg, CEO of Strainsforpains, Inc., “Our app will be expanding to hundreds of new and updated scientific and medical studies in pain management done globally over the past year”.Additionally, the company has entered into an agreement of understanding with Popped, a New York-based retailer, to expand their internet presence. Popped offers high-quality health, diet and CBD products that feature vegan and gluten-free ingredients, including gummies, body butter, and oil drops. Their products have been featured in numerous major publications including Vogue. The company is also negotiating a lease of its Pennsylvania property and exploring other potential revenue streams.Overall, we are excited about the growth potential of our company and the opportunities that lie ahead. We will continue to innovate and explore new markets to drive revenue growth and create value for our shareholders.Overview of Strainsforpains, Inc. Please visit our website at http://www.strainsforpains.com/ Mr. Shainberg is a member of the prestigious International Cannabinoid Research Society https://icrs.co/ CES 2023 is the most influential tech event in the world — the proving ground for breakthrough technologies and global innovators. https://www.ces.tech/
Strainsforpains, Inc. is an innovative healthcare data technology company located in New York, N.Y. The Company's objectives are to provide doctors, nurses, dispensaries and patients access to an APP that will allow for an advanced determination of comparison of strains or brands of cannabis combinations with major illnesses, in a user-friendly manner. The company owns a 6.5 acre facility in Pennsylvania that will be used for product production.
Safe Harbor Statement : Statements in this press release that are not historical fact may be deemed forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Although Strainsforpains, Inc. believes the expectations reflected in any forward-looking statements are based on reasonable assumptions, Strainsforpains, Inc. is unable to give any assurance that its expectations will be attained. Investors are cautioned that any such forward- looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond Strainsforpains, Inc. ability to control and those actual results may differ materially from those projected in the forward-looking statements as a result of various factors. More information about the potential factors that could affect the business and financial results is and will be included in Strainsforpains, Inc. filings with the Securities and Exchange Commission. For further info and Media Contact: Y. Simon Shainberg, Strainsforpains, Inc. : 646-481-4161 and [email protected].